Protein phosphatase 2A-activating agents
US8461362B2 · kind B2 · utility
1Cited by
11References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2010 |
| Grant date | Jun 11, 2013 |
| Priority date | — |
| Expiry date | Jun 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tocopheryl succinate derivatives according to formula I:are described. These compounds increase the activity of protein phosphatase 2A, can be included in pharmaceutical compositions, and can be used for the treatment of androgen receptor-dependent cancers such as prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.